Immunotherapies are undoubtedly transforming the landscape of cancer treatment worldwide. By harnessing the body's immune ...

Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

Background and objectives Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer.

Today, the U.S. House of Representatives passed a Congressional Review Act Resolution of Disapproval (CRA) to repeal an important air pollution rule.